TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the time course of changes in laboratory biomarkers in patients with rheumatoid arthritis (RA) 2, 4, and 8 weeks after the initiation of tocilizumab (TCZ) therapy. Subjects and methods. Forty-two RA patients receiving two intravenous infusions of TCZ (8 mg/kg each) at a 4-week in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: E N Aleksandrova, E Yu Panasyuk, A S Avdeyeva, A A Novikov, G V Lukina, M V Cherkasova, N V Klimova, E L Nasonov
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: IMA-PRESS LLC 2011-06-01
Saila:Научно-практическая ревматология
Gaiak:
rheumatoid arthritis, interleukin-6
interleukin-6 receptors
tocilizumab, erythrocyte sedimentation rate
c-reactive protein, igm/iga rheumatoid factor
anti-cyclic citrullinated peptide antibodies
anti-modified citrullinated vimentin antibodies
Sarrera elektronikoa:https://rsp.mediar-press.net/rsp/article/view/705
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak